Jade Biosciences
Waltham
About Jade Biosciences
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $575.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2025)
- Ticker: nasdaq:JBIO
- Website: jadebiosciences.com
- Phone: [email protected]
Industries & Categories
Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/jade-biosciences-15438 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.